Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2007, p. 2580-2589, Vol. 45, No. 8
0095-1137/07/$08.00+0 doi:10.1128/JCM.02554-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Madeleine Okome-Nkoumou,5
Chantal Nzamba,6
Maryvonne Kombila,4
Isabelle Accoceberry,3 and
Marc Thellier1,2*
Unité INSERM 511, CHU Pitié-Salpêtrière, 91 Bd de l'Hôpital, 75013 Paris, France,1 Assistance Publique Hôpitaux de Paris, Laboratoire de Parasitologie-Mycologie, CHU Pitié-Salpêtrière, 47 Bd de l'Hôpital, 75013 Paris, France,2 Laboratoire de Parasitologie-Mycologie, CHU de Saint André, 1 rue Jean Burguet, 33075 Bordeaux, France,3 Département de Parasitologie-Mycologie, Université des Sciences de la Santé, B.P. 4009, Libreville, Gabon,4 Unité des Maladies Infectieuses, Fondation Jeanne Ebori, B.P. 861, Libreville, Gabon,5 Centre de Traitement Ambulatoire, Hôpital Général de Libreville, Gabon,6 Génomique Analytique, Université Pierre et Marie Curie-Paris 6, 4 Place Jussieu, 75005 Paris, France7
Received 20 December 2006/ Returned for modification 27 March 2007/ Accepted 22 May 2007
Intestinal microsporidiosis due to Enterocytozoon bieneusi is a leading cause of chronic diarrhea in severely immunocompromised human immunodeficiency virus (HIV)-positive patients. It may be a public health problem in Africa due to the magnitude of the HIV pandemic and to poor sanitary conditions. We designed two prevalence studies of E. bieneusi in Central Africa, the first with HIV-positive patients from an urban setting in Gabon and the second with a nonselected rural population in Cameroon. Stool samples were analyzed by an immunofluorescence antibody test and PCR. Twenty-five out of 822 HIV-positive patients from Gabon and 22 out of 758 villagers from Cameroon were found to be positive for E. bieneusi. The prevalence rates of the two studies were surprisingly similar (3.0% and 2.9%). Genotypic analysis of the internal transcribed spacer region of the rRNA gene showed a high degree of diversity in samples from both countries. In Gabon, 15 isolates showed seven different genotypes: the previously reported genotypes A, D, and K along with four new genotypes, referred to as CAF1, CAF2, CAF3, and CAF4. In Cameroon, five genotypes were found in 20 isolates: the known genotypes A, B, D, and K and the new genotype CAF4. Genotypes A and CAF4 predominated in Cameroon, whereas K, CAF4, and CAF1 were more frequent in Gabon, suggesting that different genotypes present differing risks of infection associated with immune status and living conditions. Phylogenetic analysis of the new genotype CAF4, identified in both HIV-negative and HIV-positive subjects, indicates that it represents a highly divergent strain.
Published ahead of print on 30 May 2007.
Present address: Institut Catholique d'Etudes Supérieures, La Roche-sur-Yon, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»